Chronic graft-versus-host disease after allogeneic bone marrow transplantation from an unrelated donor: Incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program

British Journal of Haematology

Volumn 137, Issue 2, 2007, Pages 142-151

  Ozawa, Shinichi ^a   Nakaseko, Chiaki ^a   Nishimura, Miki ^a   Maruta, Atsuo ^b   Cho, Ryuko ^a   Ohwada, Chikako ^a   Sakamaki, Hisashi ^c   Sao, Hiroshi ^d   Mori, Shin Ichiro ^e   Okamoto, Shinichiro ^f   Miyamura, Kouichi ^g   Kato, Shunichi ^h   Kawase, Takakazu ⁱ   Morishima, Yasuo ⁱ   Kodera, Yoshihisa ^g  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KANAGAWA CANCER CENTER   (Japan)

^c TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^d Meitetsu Hospital   (Japan)

^e NATIONAL CANCER CENTER HOSPITAL   (Japan)

^f KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

^h TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁱ AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

Chronic graft versus host disease; Graft versus leukaemia effect; Japan Marrow Donor Program; Relapse; Unrelated bone marrow transplantation

Indexed keywords

CYCLOSPORIN A; HLA A ANTIGEN; HLA B ANTIGEN; METHOTREXATE; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; AGED; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER DIAGNOSIS; CANCER RELAPSE; CANCER SURVIVAL; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC MYELOID LEUKEMIA; DEATH; DISEASE ASSOCIATION; DONOR; FEMALE; GRAFT RECIPIENT; HEMATOLOGIC MALIGNANCY; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEWBORN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SURVIVAL TIME; THROMBOCYTE COUNT; WHOLE BODY RADIATION;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; EPIDEMIOLOGIC METHODS; FEMALE; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HISTOCOMPATIBILITY TESTING; HUMANS; INFANT; INFANT, NEWBORN; JAPAN; MALE; MIDDLE AGED; PROGNOSIS; RECURRENCE; SEVERITY OF ILLNESS INDEX;

EID: 33947509068     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2007.06543.x     Document Type: Article

References (36)

1. Akpek, G., Zahurak, M.L., Piantadosi, S., Margolis, J., Doherty, J., Davidson, R. & Vogelsang, G.B. (2001) Development of a prognostic model for grading chronic graft-versus-host disease. Blood, 97, 1219-1226.
2. Akpek, G., Lee, S.J., Flowers, M.E., Pavletic, S.Z., Arora, M., Lee, S., Piantadosi, S., Guthrie, K.A., Lynch, J.C., Takatu, A., Horowitz, M.M., Antin, J.H., Weisdorf, D.J., Martin, P.J. & Vogelsang, G.B. (2003) Performance of a new clinical grading system for chronic graft-versus-host disease: a multicenter study. Blood, 102, 802-809.
3. Armitage, J.O. (1994) Bone marrow transplantation. New England Journal of Medicine, 330, 827-838.
4. Atkinson, K. (1990) Chronic graft-versus-host disease. Bone Marrow Transplant, 5, 69-82.
5. Atkinson, K., Horowitz, M.M., Gale, R.P., van Bekkum, D.W., Gluckman, E., Good, R.A., Jacobsen, N., Kolb, H.J., Rimm, A.A., Ringden, O., Rozman, C., Sobocinski, K.A., Zwaan, F.E. & Bortin, M.M. (1990) Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. Blood, 75, 2459-2464.
6. Atsuta, Y., Suzuki, R., Yamamoto, K., Terakura, S., Iida, H., Kohno, A., Naoe, T., Yano, K., Wakita, A., Taji, H., Hamaguchi, M., Kodera, Y., Sao, H., Morishima, Y., Hamajima, N. & Morishita, Y. (2006) Risk and prognostic factors for Japanese patients with chronic graft-versus-host disease after bone marrow transplantation. Bone Marrow Transplant, 37, 289-296.
7. Baron, F., Maris, M.B., Sandmaier, B.M., Storer, B.E., Sorror, M., Diaconescu, R., Woolfrey, A.E., Chauncey, T.R., Flowers, M.E., Mielcarek, M., Maloney, D.G. & Storb, R. (2005) Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Journal of Clinical Oncology, 23, 1993-2003.
8. Cox, D.R. (1972) Regression models and life-tables. Journal of the Royal Statistical Society Series B (Statistical Methodology), 34, 187-220.
9. Davies, S.M., Kollman, C., Anasetti, C., Antin, J.H., Gajewski, J., Casper, J.T., Nademanee, A., Noreen, H., King, R., Confer, D. & Kernan, N.A. (2000) Engraftment and survival after unrelated-donor bone marrow transplantation: a report from the national marrow donor program. Blood, 96, 4096-4102.
10. Duell, T., van Lint, M.T., Ljungman, P., Tichelli, A., Socie, G., Apperley, J.F., Weiss, M., Cohen, A., Nekolla, E. & Kolb, H.J. (1997) Health and functional status of long-term survivors of bone marrow transplantation. EBMT Working Party on Late Effects and EULEP Study Group on Late Effects. European Group for Blood and Marrow Transplantation. Annals of Internal Medicine, 126, 184-192.
11. Farag, S.S. (2004) Chronic graft-versus-host disease: where do we go from here? Bone Marrow Transplant, 33, 569-577.
12. Gray, R.J. (1988) A class of K-sample tests for comparing the cumulative incidence of a competing risk. Annals of Statistics, 16, 1141-1154.
13. Greinix, H.T., Fae, I., Schneider, B., Rosenmayr, A., Mitterschiffthaler, A., Pelzmann, B., Kalhs, P., Lechner, K., Mayr, W.R. & Fischer, G.F. (2005) Impact of HLA class I high-resolution mismatches on chronic graft-versus-host disease and survival of patients given hematopoietic stem cell grafts from unrelated donors. Bone Marrow Transplant, 35, 57-62.
14. Hansen, J.A., Gooley, T.A., Martin, P.J., Appelbaum, F., Chauncey, T.R., Clift, R.A., Petersdorf, E.W., Radich, J., Sanders, J.E., Storb, R.F., Sullivan, K.M. & Anasetti, C. (1998) Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. New England Journal of Medicine, 338, 962-968.
15. Kaplan, E.L. & Meier, P. (1958) Nonparametric estimation from incomplete observations. Journal of the American Statistical Association, 53, 457-481.
16. Kataoka, I., Kami, M., Takahashi, S., Kodera, Y., Miyawaki, S., Hirabayashi, N., Okamoto, S., Matsumoto, N., Miyazaki, Y., Morishita, Y., Asai, O., Maruta, A., Yoshida, T., Imamura, M., Hamajima, N., Matsuo, K., Harada, M. & Mineishi, S. (2004) Clinical impact of graft-versus-host disease against leukemias not in remission at the time of allogeneic hematopoietic stem cell transplantation from related donors. The Japan Society for Hematopoietic Cell Transplantation Working Party. Bone Marrow Transplant, 34, 711-719.
17. Kernan, N.A., Bartsch, G., Ash, R.C., Beatty, P.G., Champlin, R., Filipovich, A., Gajewski, J., Hansen, J.A., Henslee-Downey, J., McCullough, J., McGlave, P., Perkins, H.A., Phillips, G.L., Sanders, J., Stroncek, D., Thomas, E.D. & Blume, K.G. (1993) Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. New England Journal of Medicine, 328, 593-602.
18. Kiss, T.L., Abdolell, M., Jamal, N., Minden, M.D., Lipton, J.H. & Messner, H.A. (2002) Long-term medical outcomes and quality-of-life assessment of patients with chronic myeloid leukemia followed at least 10 years after allogeneic bone marrow transplantation. Journal of Clinical Oncology, 20, 2334-2343.
19. Kodera, Y., Morishima, Y., Kato, S., Akiyama, Y., Sao, H., Matsuyama, T., Kawa, K., Sakamaki, H., Nakagawa, S., Hirabayashi, N., Dohi, H., Okamoto, S., Hiraoka, A., Gondo, H., Tsuchida, M., O.H., Harada, M., Asano, S., Juji, T., Sasazuki, T. & Takaku, F. (1999) Analysis of 500 bone marrow transplants from unrelated donors (UR-BMT) facilitated by the Japan Marrow Donor Program: confirmation of UR-BMT as a standard therapy for patients with leukemia and aplastic anemia. Bone Marrow Transplant, 24, 995-1003.
20. Kojima, S., Matsuyama, T., Kato, S., Kigasawa, H., Kobayashi, R., Kikuta, A., Sakamaki, H., Ikuta, K., Tsuchida, M., Hoshi, Y., Morishima, Y. & Kodera, Y. (2002) Outcome of 154 patients with severe aplastic anemia who received transplants from unrelated donors the Japan Marrow Donor Program. Blood, 100, 799-803.
21. Kollman, C., Howe, C.W., Anasetti, C., Antin, J.H., Davies, S.M., Filipovich, A.H., Hegland, J., Kamani, N., Kernan, N.A., King, R., Ratanatharathorn, V., Weisdorf, D. & Confer, D.L. (2001) Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood, 98, 2043-2051.
22. Lee, S.J., Klein, J.P., Barrett, A.J., Ringden, O., Antin, J.H., Cahn, J.Y., Carabasi, M.H., Gale, R.P., Giralt, S., Hale, G.A., Ilhan, O., McCarthy, P.L., Socie, G., Verdonck, L.F., Weisdorf, D.J. & Horowitz, M.M. (2002) Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse. Blood, 100, 406-414.
23. Morishima, Y., Sasazuki, T., Inoko, H., Juji, T., Akaza, T., Yamamoto, K., Ishikawa, Y., Kato, S., Sao, H., Sakamaki, H., Kawa, K., Hamajima, N., Asano, S. & Kodera, Y. (2002) The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors. Blood, 99, 4200-4206.
24. Oh, H., Loberiza, F.R., Jr, Zhang, M.J., Ringden, O., Akiyama, H., Asai, T., Miyawaki, S., Okamoto, S., Horowitz, M.M., Antin, J.H., Bashey, A., Bird, J.M., Carabasi, M.H., Fay, J.W., Gale, R.P., Giller, R.H., Goldman, J.M., Hale, G.A., Harris, R.E., Henslee-Downey, J., Kolb, H.J., Litzow, M.R., McCarthy, P.L., Neudorf, S.M., Serna, D.S., Socie, G., Tiberghien, P. & Barrett, A.J. (2005) Comparison of graft-versus-host-disease and survival after HLA-identical sibling bone marrow transplantation in ethnic populations. Blood, 105, 1408-1416.
25. Petersdorf, E.W., Anasetti, C., Martin, P.J., Gooley, T., Radich, J., Malkki, M., Woolfrey, A., Smith, A., Mickelson, E. & Hansen, J.A. (2004) Limits of HLA mismatching in unrelated hematopoietic cell transplantation. Blood, 104, 2976-2980.
26. Remberger, M., Kumlien, G., Aschan, J., Barkholt, L., Hentschke, P., Ljungman, P., Mattsson, J., Svennilson, J. & Ringden, O. (2002) Risk factors for moderate-to-severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation, 8, 674-682.
27. Ringden, O., Paulin, T., Lonnqvist, B. & Nilsson, B. (1985) An analysis of factors predisposing to chronic graft-versus-host disease. Experimental Hematology, 13, 1062-1067.
28. Shulman, H.M., Sullivan, K.M., Weiden, P.L., McDonald, G.B., Striker, G.E., Sale, G.E., Hackman, R., Tsoi, M.S., Storb, R. & Thomas, E.D. (1980) Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. American Journal of Medicine, 69, 204-217.
29. Socie, G., Stone, J.V., Wingard, J.R., Weisdorf, D., Henslee-Downey, P.J., Bredeson, C., Cahn, J.Y., Passweg, J.R., Rowlings, P.A., Schouten, H.C., Kolb, H.J. & Klein, J.P. (1999) Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. New England Journal of Medicine, 341, 14-21.
30. Storb, R., Prentice, R.L., Sullivan, K.M., Shulman, H.M., Deeg, H.J., Doney, K.C., Buckner, C.D., Clift, R.A., Witherspoon, R.P., Appelbaum, F.A., Sanders, J.E., Stewart, P.S. & Thomas, E.D. (1983) Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblings. Annals of Internal Medicine, 98, 461-466.
31. Sullivan, K.M. (1999) Graft-Versus-Host Disease. Blackwell Scientific Publishing, Boston, MA.
32. Sullivan, K.M., Weiden, P.L., Storb, R., Witherspoon, R.P., Fefer, A., Fisher, L., Buckner, C.D., Anasetti, C., Appelbaum, F.R., Badger, C., Beatty, P., Bensinger, W., Berenson, R., Bigelow, C., Cheever, M.A., Clift, R., Deeg, H.J., Doney, K., Greenberg, P., Hansen, J.A., Hill, R., Loughran, T., Martin, P., Neiman, P., Petersen, F.B., Sanders, J., Singer, J., Stewart, P. & Thomas, E.D. (1989) Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia. Blood, 73, 1720-1728.
33. Sullivan, K.M., Agura, E., Anasetti, C., Appelbaum, F., Badger, C., Bearman, S., Erickson, K., Flowers, M., Hansen, J., Loughran, T., Martin, P., Mathews, D., Petersdorf, E., Radich, J., Riddell, S., Rovira, D., Sanders, J., Schuening, F., Siadek, M., Storb, R. & Witherspoon, R. (1991) Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Seminars in Hematology, 28, 250-259.
34. Vogelsang, G.B. (2001) How I treat chronic graft-versus-host disease. Blood, 97, 1196-1201.
35. Weiden, P.L., Sullivan, K.M., Flournoy, N., Storb, R. & Thomas, E.D. (1981) Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation. New England Journal of Medicine, 304, 1529-1533.
36. Zecca, M., Prete, A., Rondelli, R., Lanino, E., Balduzzi, A., Messina, C., Fagioli, F., Porta, F., Favre, C., Pession, A. & Locatelli, F. (2002) Chronic graft-versus-host disease in children: incidence, risk factors, and impact on outcome. Blood, 100, 1192-1200.